ÖÐÎÄÃû³Æ £º Í·æßËûà¤
ÆäËûÖÐÎÄÃû³Æ £º ¸´´ïÐÀ£»Í·æßËû¶¨£»Í·æßàç¼×ôÈë¿£»Í·æßËþÆë¶¨£»àç¼×Ëáë¿Í·æß¾úËØ£»¿¸´¶¨£»(6R,7R)-7-(((2-°±»ù-4-àçßò»ù)-((1-ôÈ»ù-1-¼×»ùÒÒÑõ»ù)Ñǰ±»ù)ÒÒõ£»ù)°±»ù)-2-ôÈ»ù-8-Ñõ´ú-5-ÁòÔÓ-1-µªÔÓË«»·(4.2.0)ÐÁ-2-Ï©-3-¼×»ùßÁà¤æfÄÚÑΣ»Í·æßÆë¶¨
Ó¢ÎÄÃû³Æ £º Ceftazidime
ÆäËûÓ¢ÎÄÃû³Æ £º 1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino] acetyl] amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-en-3-yl]methyl]pyridinum hydroxide inner salt
C A S £º 72558-82-8
C22H22N6O7S2=546.58
¼¶ ±ð £º BR
º¬ Á¿ £º ¡Ý88.0%
ÐÔ ×´ £º ÎÞÉ«½á¾§»ò°×É«·ÛÄ©
Óà ; £º Éú»¯Ñо¿¡£µÚÈý´ú¹ãÆ×Í·æß¾úËØ£¬¶Ô¶àÖÖ¦Â-ÄÚõ£°·Ã¸Îȶ¨£¬¶Ô¸ïÀ¼ÑôÐÔ¾úºÍÒõÐÔ¾úÒÔ¼°ÑáÑõ¾úÖê¾ùÓнÏÇ¿µÄɱ¾ú×÷Ó㬶ÔÂÌŧ¸Ë¾úÓиßЧ£¬ÊÇΩһµÄÒ»¸öÄÜ´úÌæ°±»ùÌÇÜÕÀàµÄÍ·æßÀ࿹ÉúËØ
±£ ´æ £º 2¡«8¡æ
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
